Literature DB >> 1184737

25-hydroxycholecalciferol stimulation of muscle metabolism.

S J Birge, J G Haddad.   

Abstract

Intact diaphragms from vitamin D-deficient rats were incubated in vitro with [3H]leucine. Oral administration of 10 mug (400 U) of cholecalciferol 7 h before incubation increased leucine incorporation into diaphragm muscle protein by 136% (P less than 0.001) of the preparation from untreated animals. Nephrectomy did not obliterate this response. ATP content of the diaphragm muscle was also enhanced 7 h after administration of the vitamin. At 4 h after administration of cholecalciferol, serum phosphorus concentration was reduced by 0.7 mg/100 ml (P less than 0.025) and the rate of inorganic 32PO4 accumulation by diaphragm muscle was increased by 18% (P less than 0.025) over the untreated animals. Increasing serum phosphate concentration of the vitamin D-deficient animals by dietary supplementation with phosphate for 3 days failed to significantly enhance leucine incorporation into protein. However, supplementation of the rachitogenic, vitamin D-deficient diet with phosphorus for 3 wk stimulated the growth of the animal and muscle ATP levels. This increase in growth and muscle ATP content attributed to the addition of phosphorus to the diet was less than the increase in growth and muscle ATP levels achieved by the addition of both phosphorus and vitamin D to the diet. To eliminate systemic effects of the vitamin, the epitrochlear muscle of the rat foreleg of vitamin D-depleted rats was maintained in tissue culture. Addition of 20 ng/ml of 25-hydroxycholecalciferol (25-OHD3) to the medium enhanced ATP content of the muscle and increased leucine incorporation into protein. Vitamin D3 at a concentration of 20 mug/ml and 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) at a concentration of 500 pg/ml were without effect. Analysis of muscle cytosol in sucrose density gradients revealed a protein fraction which specifically bound 25-OHD3 and which demonstrated a lesser affinity for 1,25-(OH)2D3. These studies suggest that 25-OHD3 may influence directly the intracellular accumulation of phosphate by muscle and thereby play an important role in the maintenance of muscle metabolism and function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1184737      PMCID: PMC301971          DOI: 10.1172/JCI108184

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Intestinal transport of phosphate: action of vitamin D, calcium, and potassium.

Authors:  H E HARRISON; H C HARRISON
Journal:  Am J Physiol       Date:  1961-12

2.  A method for the biological assay of phosphaturic activity in parathyroid extracts.

Authors:  A D KENNY; P L MUNSON
Journal:  Endocrinology       Date:  1959-04       Impact factor: 4.736

3.  Vitamin D and growth.

Authors:  H STEENBOCK; D C HERTING
Journal:  J Nutr       Date:  1955-12-10       Impact factor: 4.798

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite.

Authors:  M F Holick; H F DeLuca
Journal:  J Lipid Res       Date:  1971-07       Impact factor: 5.922

6.  Intestinal absorption of phosphate in the chick: effect of vitamin D and other parameters.

Authors:  R H Wasserman; A N Taylor
Journal:  J Nutr       Date:  1973-04       Impact factor: 4.798

7.  Myopathy associated with anticonvulsant osteomalacia.

Authors:  C D Marsden; E H Reynolds; V Parsons; R Harris; L Duchen
Journal:  Br Med J       Date:  1973-12-01

8.  Biochemical studies on some aspects of protein metabolism in vitamin-D deficient rats.

Authors:  A A al-Gauhari; S A al-Nagdy; M E el-Sabbagh; E A Eisa
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1974-03-01

9.  Myopathy, osteomalacia and hyperparathyroidism.

Authors:  R Smith; G Stern
Journal:  Brain       Date:  1967-09       Impact factor: 13.501

10.  1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture.

Authors:  L G Raisz; C L Trummel; M F Holick; H F DeLuca
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

View more
  41 in total

Review 1.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

2.  Bone disease in the elderly.

Authors:  R Smith
Journal:  Proc R Soc Med       Date:  1976-12

3.  Dietary vitamin D3 supplementation at 10× the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2012-05-17       Impact factor: 5.243

4.  The role of phosphate in the action of vitamin D on the intestine.

Authors:  S J Birge; R Miller
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

Review 5.  Genetic influences in sport and physical performance.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-10-01       Impact factor: 11.136

6.  Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogs.

Authors:  A I Jacob; J M Canterbury; G Gavellas; P W Lambert; J J Bourgoignie
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

7.  Effects of vitamin D3 metabolites on calcium fluxes in intact chicken skeletal muscle and myoblasts cultured in vitro.

Authors:  D L Giuliani; R L Boland
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

Review 8.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

9.  Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease.

Authors:  Shina Menon; Rudolph P Valentini; Guillermo Hidalgo; Lena Peschansky; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2008-06-25       Impact factor: 3.714

Review 10.  Vitamin D and human skeletal muscle.

Authors:  B Hamilton
Journal:  Scand J Med Sci Sports       Date:  2009-10-05       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.